A Pilot Study To Assess the Suitability of Riboflavin As a Surrogate Marker of Breast Cancer Resistance Protein in Healthy Participants-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Pilot Study To Assess the Suitability of Riboflavin As a Surrogate Marker of Breast Cancer Resistance Protein in Healthy Participants

Published:2024-01-31 Issue:2 Volume:390 Page:162-173
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Shen Hong,Huo Runlan,Zhang Yueping,Wang Linna,Tong Nian,Chen Weiqi,Paris Andrew J.,Mensah Kofi,Chen Min,Xue Yongjun,Li Wenying,Sinz Michael

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Reference52 articles.

1. Oral sulfasalazine as a clinical BCRP probe substrate: pharmacokinetic effects of genetic variation (C421A) and pantoprazole coadministration;Adkison;J Pharm Sci,2010

2. Using endogenous biomarkers to derisk assessment of transporter-mediated drug-drug interactions: a scientific perspective;Arya;J Clin Pharmacol,2022

3. Clinical Probes and Endogenous Biomarkers as Substrates for Transporter Drug-Drug Interaction Evaluation: Perspectives From the International Transporter Consortium

4. Quantitative prediction of breast cancer resistant protein mediated drug-drug interactions using physiologically-based pharmacokinetic modeling;Costales;CPT Pharmacometrics Syst Pharmacol,2021

5. In vitro risk assessment of AZD9056 perpetrating a transporter-mediated drug–drug interaction with methotrexate

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utility of Biomarker‐Informed Drug Interaction Evaluation in Drug Development and Regulatory Decision Making;Clinical Pharmacology & Therapeutics;2024-09-09

2. Advancing structural elucidation of conjugation drug metabolites in metabolite profiling with novel electron‐activated dissociation;Rapid Communications in Mass Spectrometry;2024-08-19

3. Innovative Approaches to Optimize Clinical Transporter Drug–Drug Interaction Studies;Pharmaceutics;2024-07-26

4. Ticagrelor modestly raises plasma riboflavin concentration in humans and inhibits riboflavin transport by BCRP and MRP4;Clinical Pharmacology & Therapeutics;2024-07-22

5. Brightening the Path: Riboflavin Illuminates Breast Cancer Resistance Protein Monitoring;Journal of Pharmacology and Experimental Therapeutics;2024-07-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3